2000
DOI: 10.1016/s0010-7824(99)00121-3
|View full text |Cite
|
Sign up to set email alerts
|

The “boom and bust phenomenon”: the hopes, dreams, and broken promises of the contraceptive revolution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
30
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 18 publications
0
30
0
Order By: Relevance
“…Of note, they were similar in their relative dislike of Norplant, which may not be surprising given the negative press about the method during the 1990s (Boonstra et al, 2000). They also were alike in their relatively positive views of male condoms and somewhat less positive views of female condoms, except that men were more likely than women to perceive that male condoms are highly effective in preventing pregnancy.…”
Section: Discussionmentioning
confidence: 86%
“…Of note, they were similar in their relative dislike of Norplant, which may not be surprising given the negative press about the method during the 1990s (Boonstra et al, 2000). They also were alike in their relatively positive views of male condoms and somewhat less positive views of female condoms, except that men were more likely than women to perceive that male condoms are highly effective in preventing pregnancy.…”
Section: Discussionmentioning
confidence: 86%
“…7 When exposures to exogenous estrogen and progestin in the form of OC became widespread, concerns were raised about potential effect health effects, including breast cancer risk. 21 The possible association between use of OC and breast cancer has been examined in a large number of epidemiologic studies, reviewed in detail elsewhere. 5,6,22,23 Many studies found no overall association between OC use and breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Many other reports confirm the extremely high contraceptive efficacy of injections [11][12][13][14] and implants [9,15]. Because of problems associated with difficult removals and other concerns, the six-capsule implantable contraceptive Norplant is no longer marketed in the United States [16]. Fortunately, in 2006 a single rod progestin-releasing contraceptive implant (Implanon; Organon, Roseland, NJ) received Food and Drug Administration (FDA) approval for up to 3 years of use.…”
mentioning
confidence: 99%